It has been reported that elevated plasma HSP90AA1 levels are specific to malignant tumors and patients with metastatic liver or breast tumors have higher plasma HSP90AA1 levels than those without metastasis (Wang et al., 2009). Here, HSP90AA1 is linked to breast neoplasm.